Jennifer S. Temel, MD, on The Changing Conversation Around Prognostication

2016 Palliative Care in Oncology Symposium
Tweet this page

Jennifer S. Temel, MD, of Massachusetts General Hospital, discusses increasing prognostic uncertainty in light of targeted treatments and immunotherapies, and the difficulty predicting who will benefit.

Advertisement

Advertisement



Advertisement